{"id":"qls1128","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Limited public information is available on QLS1128's precise mechanism of action. As a phase 3 candidate from Qilu Pharmaceutical, it represents an investigational compound under active clinical evaluation, but detailed mechanistic data have not been widely disclosed in accessible literature.","oneSentence":"QLS1128 is a small molecule inhibitor targeting a specific molecular pathway in phase 3 development by Qilu Pharmaceutical.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:30:51.779Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT05758519","phase":"PHASE3","title":"A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19","status":"UNKNOWN","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2023-03-07","conditions":"COVID-19","enrollment":1220},{"nctId":"NCT05689203","phase":"PHASE2","title":"A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19","status":"UNKNOWN","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2022-12-30","conditions":"COVID-19","enrollment":360},{"nctId":"NCT05458076","phase":"PHASE1","title":"A Study of QLS1128 and in Combination With Ritonavir in Healthy Participants","status":"UNKNOWN","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2022-07-03","conditions":"COVID-19","enrollment":86}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"QLS1128","genericName":"QLS1128","companyName":"Qilu Pharmaceutical Co., Ltd.","companyId":"qilu-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}